The effect of full-spectrum cannabis leaf extract on pain, inflammation, and quality of sleep: Case series

Abstract

Abstract Inflammation and pain are two of the most typical signs of a pain syndrome. Conventional treatments have been related to an increase in adverse effects like gastrointestinal issues. Medical cannabis (MC) has gained popularity as a new alternative treatment for pain syndrome patients. We hereby present a series of five cases with comparable clinical symptoms. All patients had raised C-reactive protein levels, severe pain, insomnia, and varying degrees of muscle stiffness. The patients were prescribed Cannazo India’s Painaid 3000 mg/15 mL, full-spectrum MC leaf extract-based tincture. The oil-based tincture was given sublingually at night for 1 month, and the initial dose of 5–10 drops was gradually reduced owing to Painaid’s rapid pain relief and anti-inflammatory actions. For symptom assessment, the screening tools Numeric Pain Rating Scale, Ashworth Scale, and Regensburg Insomnia Scale were employed. This study’s primary result was a 70%–99% reduction in pain, spasticity, and inflammation. There were no documented side effects. In addition, the patients’ sleep patterns and sleep quality improved with time. In a nutshell, full-spectrum cannabis extract-based medicines like Painaid, when taken as indicated, are the key in treating pain conditions.